Results for &quot;&quot;Poliovirus Vaccine, Inactivated&quot;&quot;[mesh_terms]

Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial.

Jolice P van den Berg, Elisabeth A M Westerbeek, Fiona R M van der Klis, Guy A M Berbers, Harrie N Lafeber, Ruurd M van Elburg

PloS one 2014;8(8):e70904

Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.

Ali Faisal Saleem, Ondrej Mach, Farheen Quadri, Asia Khan, Zaid Bhatti, Najeeb Ur Rehman, Sohail Zaidi, William C Weldon, Steven M Oberste, Maha Salama, Roland W Sutter, Anita K M Zaidi

Vaccine 2016;33(24):2757-63

Vitamin A supplementation and risk of atopy: long-term follow-up of a randomized trial of vitamin A supplementation at six and nine months of age.

Nicholas Kiraly, Aliu Balde, Ida Marie Lisse, Helle Brander Eriksen, Peter Aaby, Christine Stabell Benn

BMC pediatrics 2014;13():190

Effect of booster doses of poliovirus vaccine in previously vaccinated children, Clinical Trial Results 2013.

Muhammad Atif Habib, Sajid Soofi, Ondrej Mach, Tariq Samejo, Didar Alam, Zaid Bhatti, William C Weldon, Steven M Oberste, Roland Sutter, Zulfiqar A Bhutta

Vaccine 2017;34(33):3803-9

Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).

Daniel Cowley, Rini Mulia Sari, Amanda Handley, Emma Watts, Novilia S Bachtiar, Jarir At Thobari, Cahya Dewi Satria, Nada Bogdanovic-Sakran, Hera Nirwati, Francesca Orsini, Katherine J Lee, Carl D Kirkwood, Yati Soenarto, Julie E Bines

Vaccine 2020;37(49):7233-7239

Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial.

Luis Rivera, Rasmus S Pedersen, Lourdes Peña, Klaus J Olsen, Lars V Andreasen, Ingrid Kromann, Pernille I Nielsen, Charlotte Sørensen, Jes Dietrich, Ananda S Bandyopadhyay, Birgit Thierry-Carstensen

The Lancet. Infectious diseases 2017;17(7):745-753

Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.

Pauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, M Steven Oberste, Claire J Boog, Hiromasa Okayasu, Roland W Sutter, Wilfried A M Bakker

Vaccine 2014;31(47):5531-6

First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12months and 5years of age.

Line M Lindgren, Pernille N Tingskov, Annette H Justesen, Bettina S Nedergaard, Klaus J Olsen, Lars V Andreasen, Ingrid Kromann, Charlotte Sørensen, Jes Dietrich, Birgit Thierry-Carstensen

Vaccine 2017;35(4):596-604

Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial.

Thomas Nørrelykke Nissen, Nina Marie Birk, Dorthe Lisbeth Jeppesen, Ole Pryds, Lone Graff Stensballe, Gaby Smits, Mihai G Netea, Fiona van der Klis, Christine Stabell Benn

Vaccine 2017;35(16):2084-2091

Effect of routine vaccination on aluminum and essential element levels in preterm infants.

Tammy Z Movsas, Nigel Paneth, Wilson Rumbeiha, Justin Zyskowski, Ira H Gewolb

JAMA pediatrics 2013;167(9):870-2

An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status.

Caroline S Broome, Francis McArdle, Janet A M Kyle, Francis Andrews, Nicola M Lowe, C Anthony Hart, John R Arthur, Malcolm J Jackson

The American journal of clinical nutrition 2004;80(1):154-62

Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.

Fernando A Guerra, Mark M Blatter, David P Greenberg, Michael Pichichero, Fernando R Noriega

Pediatrics 2009;123(1):301-12

Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine.

Francisco Gimenez-Sanchez, Dorothee M Kieninger, Kathrin Kueper, Federico Martinon-Torres, Enrique Bernaola, Javier Diez-Domingo, Kathrin Steul, Christine Juergens, Alejandra Gurtman, Peter Giardina, John Z Liang, William C Gruber, Emilio A Emini, Daniel A Scott

Vaccine 2011;29(35):6042-8

Immunological persistence in 4-6 and 7-9 year olds previously vaccinated in infancy with hexavalent DTPa-HBV-IPV/Hib.

Michael Zinke, Johann Disselhoff, Britta Gartner, Jeanne-Marie Jacquet

Human vaccines 2012;6(2):189-93